Current Signal Transduction Therapy

Journal Title
Current Signal Transduction Therapy

CURR SIGNAL TRANSD T

ISSN / eISSN
1574-3624
Aims and Scope
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.
Subject Area

N/A

CiteScore
2.00 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q3 #173/260
Medicine - Endocrinology Q4 #103/119
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
- -
H-index
15
Country/Area of Publication
U ARAB EMIRATES
Publisher
Bentham Science Publishers B.V.
Publication Frequency
Tri-annual
Year Publication Started
2006
Annual Article Volume
19
Open Access
NO
Contact
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started